NomophobiaNCT06656013
Motivational Interview and Nomophobia
A study testing Motivational Interview in people with Nomophobia and Smartphone Addiction, run by Sultan Ayaz Alkaya at 1 site in Turkey (Türkiye).
Trial summary
A preparation session and a motivational interview consisting of 4 sessions will be applied to nursing students. Data collection tools will be applied before, after and at 3 months. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Nomophobia, Smartphone Addiction
- What is being tested?
- Motivational Interview
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 21 Oct 2024to 30 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- being over 18 years of age
- being a first-year nursing student
- agreeing to participate in the research
Who cannot join
- having problems understanding and speaking Turkish
- having visual or hearing impairment
- having a neuropsychiatric disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Motivational Interviewing on the Level of Nomophobia and Smartphone Addiction of Nursing Students
A preparation session and a motivational interview consisting of 4 sessions will be applied to nursing students. Data collection tools will be applied before, after and at 3 months.
- Conditions
- Nomophobia, Smartphone Addiction
- Being tested
- Motivational Interview
- Keywords
- nursing student, smartphone addiction, nomophobia, motivational interview
- Medical subject headings
- Internet Addiction Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motivational InterviewBehavioural
After the preparation session, 4 sessions of motivational interviewing will be applied. Motivational interviewing techniques will be used in the interviews to target behavioral change.
| Study group | Role | What they receive |
|---|---|---|
| Motivational Interview | Experimental | Preparation and motivational interviewing practice consisting of 4 sessions Receives: Behavioral: Motivational Interview |
| Control | No intervention | There will be no intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Nomophobia Scale
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Measured: Pre-test
Smartphone Addiction Scale-Short Form
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Measured: Pre-test
Nomophobia Scale
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Measured: 6 weeks after pre-test
Smartphone Addiction Scale-Short Form
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Measured: 6 weeks after pre-test
Nomophobia Scale
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Measured: Follow-up (18 weeks after pre-test)
Smartphone Addiction Scale-Short Form
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Measured: Follow-up (18 weeks after pre-test)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2024
- Study start21 Oct 2024
- Primary completion30 Mar 2025
- Study completion30 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for NomophobiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sultan Ayaz Alkaya
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Sultan Ayaz Alkaya, Gazi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06656013
- Sponsor's protocol ID
- 2024 - 954
- Status last verified
- Jul 2025
- First submitted
- 9 Oct 2024
- Last updated
- 14 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Motivational Interviewing on the Level of Nomophobia and Smartphone Addiction of Nursing Students
- ClinicalTrials.gov ID
- NCT06656013
- Acronym / sponsor ID
- 2024 - 954
- Conditions
- Nomophobia, Smartphone Addiction
- Keywords
- nursing student, smartphone addiction, nomophobia, motivational interview
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Sultan Ayaz AlkayaUniversity, hospital or other
- Study start
- 21 Oct 2024 (actual)
- Primary completion
- 30 Mar 2025 (actual)
- Study completion
- 30 Jun 2025 (actual)
- First posted
- 24 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A preparation session and a motivational interview consisting of 4 sessions will be applied to nursing students. Data collection tools will be applied before, after and at 3 months.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Motivational Interview | Experimental | Behavioral: Motivational InterviewPreparation and motivational interviewing practice consisting of 4 sessions |
| Control | No intervention | –There will be no intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- being over 18 years of age
- being a first-year nursing student
- agreeing to participate in the research
Key exclusion criteria (3 listed)
- having problems understanding and speaking Turkish
- having visual or hearing impairment
- having a neuropsychiatric disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motivational InterviewAfter the preparation session, 4 sessions of motivational interviewing will be applied. Motivational interviewing techniques will be used in the interviews to target behavioral change. | Behavioural | Motivational Interview |
Primary outcome
Nomophobia Scale
Time frame: Pre-test
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Smartphone Addiction Scale-Short Form
Time frame: Pre-test
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Nomophobia Scale
Time frame: 6 weeks after pre-test
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Smartphone Addiction Scale-Short Form
Time frame: 6 weeks after pre-test
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Nomophobia Scale
Time frame: Follow-up (18 weeks after pre-test)
The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.
Smartphone Addiction Scale-Short Form
Time frame: Follow-up (18 weeks after pre-test)
The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Nomophobia
Not yet recruiting
The Effect of Self-Compassion Practices on Nomophobia Symptoms in Young Adults
Nomophobia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motivational Interview in people with Nomophobia and Smartphone Addiction, run by Sultan Ayaz Alkaya at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Nomophobia Scale (time frame: Pre-test). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2025; AzTrials last refreshed its copy on 27 Oct 2026.